研究单位：[1]Binhui Biopharmaceutical Co., Ltd.[2]Peking University Cancer Hospital,Beijing,Beijing,China,100010[3]Chongqing University Cancer Hospital,Chongqing,Chongqing,China,400000[4]Fujian Cancer Hosptial,Fuzhou,Fujian,China,350000[5]Dermatology Hospital of Southern Medical University,Guangzhou,Guangdong,China,510000[6]Sun Yat-sen University Cancer Center,Guangzhou,Guangdong,China,510000[7]Guangxi Medical University Cancer Hospital,Nanning,Guangxi,China,530000[8]Hainan Cancer Hospital,Haikou,Hainan,China,570100[9]The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital,Shijiazhuang,Hebei,China,050000[10]The First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,China,150000[11]The Third People''s Hospital of Zhengzhou,Zhengzhou,Henan,China,450000[12]Hubei Cancer Hospital,Wuhan,Hubei,China,430000[13]Union Hospital Tongji Medical College Huazhong University of Science and Technology,Wuhan,Hubei,China,430000[14]Hunan Cancer Hospital,Changsha,Hunan,China,410000[15]Nanjing Drum Tower Hospital,Nanjing,Jiangsu,China,210000[16]The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China,330000[17]Jilin Cancer Hospital,Changchun,Jilin,China,130000[18]The first hospital of Jilin University,Changchun,Jilin,China,130000[19]The First Affiliated Hospital of Dalian Medical University,Dalian,Liaoning,China,116000[20]Liaoning Cancer Hospital ＆ Institute,Shenyang,Liaoning,China,116000[21]The First Affiliated Hospital of Xi''an Jiaotong University,Xi''an,Shaanxi,China,710000[22]The Affiliated Cancer Hospital of Shandong First Medical University,Jinan,Shandong,China,250000[23]Weifang People''s Hospital,Weifang,Shandong,China,261000[24]Fudan University Shanghai Cancer Center,Shanghai,Shanghai,China,200000[25]Shanxi Bethune Hospital,Taiyuan,Shanxi,China,030000[26]West China Hospital of Sichuan University,Chengdu,Sichuan,China,610000[27]Tianjin Medical University Cancer Institute ＆ Hospital,Tianjin,Tianjin,China,300000[28]The Affiliated Cancer Hospital, Xinjiang Medical University,Urumqi,Xinjiang,China,830000[29]Yunnan Cancer Hospital,Kunming,Yunnan,China,650000[30]Cancer Hospital Of The University Of Chinese Academy Of Sciences Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China,310000[31]Sir Run Run Shaw Hospital,Hangzhou,Zhejiang,China,310000
研究目的：
To evaluate the efficacy of OH2 injection in patients with unresectable or metastatic melanoma who have failed at least second-line standard therapy, using investigator-selected salvage chemotherapy or best supportive care (BSC) as controls.
